- The number of “flu deaths” each year, used to scare people into getting vaccinated, is grossly inaccurate. There are several reasons for this, the main one being that so-called “flu deaths” also include deaths from pneumonia and influenza–like illnesses, and respiratory and circulatory causes .
- Seasonal flu vaccine makes you more susceptible to other respiratory infections .
- Influenza-related deaths have actually increased, as vaccination rates have increased .
- Numerous reviews have found that there is evidence of widespread manipulation of data in flu vaccine studies, and what’s more, no measurable benefits in vaccinating healthcare workers, young children, healthy adults, pregnant women or the elderly [4-8]. Actually, let’s just say that there are no measurable benefits for anybody .
- Flu vaccine induces auto-antibodies against gangliosides in the brain . Gangliosides are found throughout the body, especially the central nervous system and play an important role in many cell functions.
- Flu vaccine makes people more susceptible to pandemic influenza strains .
- After three consecutive years, people who receive the annual flu vaccine, are more likely to get influenza .
- The prestigious Cochrane Review found that 71 people would need to be vaccinated in order to prevent one case of influenza…while at the same time concluding that only 10% of the studies included in their review had good methodological quality. Therefore, even this unimpressive finding is likely to be vastly over-inflated .
- The flu vaccine only targets A and B strains of influenza, which account for approximately 10% of known circulating strains. Against this 10%, vaccine efficacy can be as low as 18% when strains have not been well matched, remembering that “efficacy” is based on ability to produce antibodies, which does not equal immunity anyway .
- Multidose flu vaccines (such as trivalent and quadrivalent vaccines) contain thimerosal, which is 50% ethylmercury by weight. Ethylmercury is highly toxic, converts to inorganic mercury, persists in the brain for many years. Oh, and it also suppresses the immune system, leaving you worse off overall .
 CDC. Influenza (Flu): Estimating seasonal influenza-associated deaths in the United States, https://www.cdc.gov/flu/about/disease/us_flu-related_deaths.htm. Accessed February, 2017.
 Cowling BJ, Fang VJ, Nishiura H, et al. Increased risk of non-influenza respiratory virus infections associated with receipt of inactivated influenza vaccine, Clin Infect Dis, 2012, 54(12):1778-1783.
 Simonson L, Reichert TA, Blackwelder WC, Miller MA, Benefits of influenza vaccination on influenza-related mortality among elderly in the US: an unexpected finding, Intern Cong Series, 2004, 1263: 163-167.
 Jefferson T, Di Pietrantoni C, Rivetti A, et al. Vaccines for preventing influenza in healthy adults, Cochrane Database Syst Rev, 2010, 7(7): CD001269.
 Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who work with the elderly, Cochrane Database Syst Rev, 2010, 17(2): CD005187.
 Szilagyi PG, Faibrother G, Griffin MR, et al. Influenza vaccine effectiveness among children 6-59 months of age during 2 influenza seasons: a case-cohort study, Arch Pediatr Adolesc Med, 2008, 162(10): 943-951.
 France EK, Smith-Ray R, McClure D, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants, Arch Pediatr Adolesc Med, 2006, 160(12): 1277-1283.
 Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza: a systematic review and meta-analysis, Lancet Infect Dis, 2012, 12(1)36-44.
 Simonsen L, Reichert TA, Viboud C, et al. Impact of influenza vaccination on seasonal mortality in the US elderly population, Arch Intern Med, 2005, 165(3): 265-272.
 Nachamkin I, Shadomy SV, Moran AP, et al. Anti-ganglioside antibody induction by swine and other influenza vaccines: insights into vaccine-associated Guillain-Barre syndrome, J Infect Dis, 2008, 198(2): 226-233.
 Bodewes R, Kreigtz JH, Baas C, et al. Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus, PLoS One, 2009, 4(5): e5538.
 Skowronski D, Chambers C, Sabaiduc S, et al. A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccination effectiveness during 2014-2015 season, Clin Infect Dis, 2016, 63(1): 21-32.
 Loison E, Poirier-Beaudouin B, Seffer V, et al. Suppression by thimerosal of ex-vivo CD4+ T-cell response to influenza vaccine and induction of apoptosis in primary memory T cells, PLoS One, 2014, 9(4): e92705.